Stimulants Stocks List

Stimulants Stocks Recent News

Date Stock Title
Nov 1 HRMY Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Oct 31 HRMY Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations
Oct 31 ZVRA Zevra Therapeutics to Report Third Quarter 2024 Financial ResultsĀ and Provide Corporate Update on Nov. 12, 2024
Oct 31 HRMY Harmony Biosciences prices secondary offering at $31 per share
Oct 31 HRMY Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders
Oct 30 ZVRA Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Oct 30 HRMY Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...
Oct 30 HRMY Q3 2024 Harmony Biosciences Holdings Inc Earnings Call
Oct 29 HRMY Harmony Biosciences Holdings announces public offering
Oct 29 HRMY Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders
Oct 29 HRMY Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat
Oct 29 HRMY Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript
Oct 29 HRMY Harmony Biosciences Holdings, Inc. 2024 Q3 - Results - Earnings Call Presentation
Oct 29 HRMY Harmony Biosciences Holdings, Inc. (HRMY) Q3 2024 Earnings Call Transcript
Oct 29 ZVRA Earnings Preview: Zevra Therapeutics (ZVRA) Q3 Earnings Expected to Decline
Oct 29 HRMY Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates
Oct 29 HRMY Harmony Biosciences GAAP EPS of $0.79, revenue of $186M
Oct 29 HRMY HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS
Oct 28 HRMY Harmony Biosciences Q3 2024 Earnings Preview
Stimulants

Stimulants (also often referred to as psychostimulants or colloquially as uppers) is an overarching term that covers many drugs including those that increase activity of the central nervous system and the body, drugs that are pleasurable and invigorating, or drugs that have sympathomimetic effects. Stimulants are widely used throughout the world as prescription medicines as well as without a prescription (either legally or illicitly) as performance-enhancing or recreational drugs. The most frequently prescribed stimulants as of 2013 were lisdexamfetamine, methylphenidate, and amphetamine. It is estimated that the percentage of the population that has abused amphetamine-type stimulants (e.g., amphetamine, methamphetamine, MDMA, etc.) and cocaine combined is between 0.8% and 2.1%.

Browse All Tags